Choriocapillaris and Retinal Vascular Alterations in Presymptomatic Alzheimer's Disease.

"Disclosure: G. Corradetti, Nidek (L); D. Oncel, None; S. Kadomoto, Canon (C), Nidek (C); X. Arakaki, None; R.A. Kloner, None; A.A. Sadun, Chiesi (C), GenSight (C), Stealth (C); S.R. Sadda, 4DMT (C), Abbvie (C), Alexion (C), Allergan (C), Alnylam Pharmaceuticals (C), Amgen (C), Apellis Pharmaceuticals (C), Astellas (C), Bayer Healthcare Pharmaceuticals (C), Biogen (C), Boehringer Ingelheim (C), Carl Zeiss Meditec (C, L, S), Catalyst Pharmaceuticals (C), CenterVue (C), Genentech (C), Gyroscope Therapeutics (C), Heidelberg Engineering (C, L, S), Hoffmann-La Roche (C), Iveric Bio (C), Janssen Pharmaceuticals (C), Merck (C), Nanoscope (C), Nidek (L), Notal Vision (C), Novartis (C, L), Optos (C), Oxurion/Thrombogenics (C), Oyster Point Pharma (C), Pfizer (C), Regeneron Pharmaceuticals (C), Samsung Bioepis (C), Topcon Medical Systems (C, L), Vertex Pharmaceuticals (C); J.W. Chan, (C)"

"Supported by the Kuen Lau Research Foundation and a grant from the National Institute on Aging, National Institutes of Health (R01AG063857)."